1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinoline
induces parkinsonism in mice; structure in first source
Also Known As:
3',4'-DHBnTIQ
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Kotake, Yaichiro:
2 articles
(09/2014 - 11/2002)
|
| 2. | Contu, Viorica Raluca:
1 article
(09/2014)
|
| 3. | Kumagai, Yoshito:
1 article
(09/2014)
|
| 4. | Miyara, Masatsugu:
1 article
(09/2014)
|
| 5. | Ohta, Shigeru:
1 article
(09/2014)
|
| 6. | Okuda, Katsuhiro:
1 article
(09/2014)
|
| 7. | Sakamoto, Shuichiro:
1 article
(09/2014)
|
| 8. | Samizo, Shigeyoshi:
1 article
(09/2014)
|
| 9. | Sanoh, Seigo:
1 article
(09/2014)
|
| 10. | Toyama, Takashi:
1 article
(09/2014)
|
Related Diseases
| 1. | Parkinsonian Disorders (Parkinsonism)
12/01/2000
- " 1-(3',4'-Dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline [3', 4'DHBnTIQ (1)] is an endogenous parkinsonism-inducing substance. " 09/01/2014
- " We investigated the interaction between ubiquitin C-terminal hydrolase L1 (UCH-L1) and the brain endogenous parkinsonism inducer 1-(3',4'-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline (3',4'DHBnTIQ). " 09/01/2014
- " We previously showed that 1-(3',4'-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline (3',4'DHBnTIQ) is an endogenous parkinsonism-inducing dopamine derivative. " 11/01/2002
- " 1-(3',4'-Dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline (3'4'DHBnTIQ) is also an endogenous parkinsonism-inducing 1BnTIQ derivative. "
|
|
Related Drugs and Biologics